Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
In patients with atrial fibrillation and stable coronary artery disease, edoxaban monotherapy led to a lower risk of a composite of death from any cause, myocardial infarction, stroke, systemic embolism, unplanned urgent revascularization, or major bleeding or clinically relevant nonmajor bleeding at 12 months than dual antithrombotic therapy. (Funded by the CardioVascular Research Foundation and others; EPIC-CAD ClinicalTrials.gov number, NCT03718559.).
Authors
- Eun‐Sun Jin (ORCID: https://orcid.org/0000-0003-1182-8244)
- Ki Won Hwang (ORCID: https://orcid.org/0000-0002-1372-330X)
- Chang Hee Kwon (ORCID: https://orcid.org/0000-0001-8716-1146)
- Eue‐Keun Choi (ORCID: https://orcid.org/0000-0002-0411-6372)
- Do‐Yoon Kang (ORCID: https://orcid.org/0000-0002-6307-0562)
- Jongmin Hwang (ORCID: https://orcid.org/0000-0001-9710-0945)
- Duk‐Woo Park (ORCID: https://orcid.org/0000-0001-6643-0239)
- Osung Kwon (ORCID: https://orcid.org/0000-0001-6857-8632)
- Hyung Oh Choi (ORCID: https://orcid.org/0000-0002-0837-8513)
- Gi‐Byoung Nam (ORCID: https://orcid.org/0000-0003-4391-5406)
- Ki‐Dong Yoo (ORCID: https://orcid.org/0000-0001-5425-1102)
- Min Soo Cho (ORCID: https://orcid.org/0000-0001-9867-4991)
- Kyoung‐Min Park (ORCID: https://orcid.org/0000-0002-5416-9691)
- Gyung‐Min Park (ORCID: https://orcid.org/0000-0001-5846-0606)
- Kyoung‐Ha Park (ORCID: https://orcid.org/0000-0002-5935-8715)
- Yong‐Seog Oh (ORCID: https://orcid.org/0000-0003-3567-6505)
- Ji Hyun Lee (ORCID: https://orcid.org/0000-0002-7162-1248)
- Ji Hyun Kim (ORCID: https://orcid.org/0000-0003-0861-2792)
- Ki‐Hun Kim (ORCID: https://orcid.org/0000-0002-6599-6895)
- Chang Hoon Lee
- Young‐Rak Cho (ORCID: https://orcid.org/0000-0001-9267-3082)
- Jung-Min Ahn
- Seung-Jung Park
- Sung-Cheol Yun
Institutions
- National University College (PR)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1056/nejmoa2407362
- Citations
- 75
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 30.15
Funders
- Cardiovascular Research Foundation
- Daiichi-Sankyo
- Daewoong Pharmaceutical Company